Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer

Post time 4 day(s) ago

Sonke, G. S., van Ommen-Nijhof, A., Wortelboer, N., van der Noort, V., Swinkels, A. C. P., Blommestein, H. M., Guerrero Paez, C., Mol, L., Beeker, A., Beelen, K., Hamming, L. C., Heijns, J. B., Honkoop, A. H., de Jong, P. C., van Rossum-Schornagel, Q. C., van Schaik-van de Mheen, C., Tol, J., Tromp-van Driel, C. S., Vrijaldenhoven, S., van Leeuwen-Stok, A. E., … SONIA Study Consortium (2024). Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer. Nature, 636(8042), 474–480. https://doi.org/10.1038/s41586-024-08035-2

Post time 4 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer